The requested article has expired, and is no longer available. Any related articles, and user comments are shown below.
© (c) Copyright Thomson Reuters 2017.Health minister to consider U.S. drug firms' views in pricing overhaul
By Tetsushi Kajimoto and Yoshifumi Takemoto TOKYO©2025 GPlusMedia Inc.
6 Comments
Login to comment
Kobe White Bar Owner
Wont happen.
Kabukilover
Big Pharma ought to sent packing. We do not need America's exorbitantly high medical cost to come to Japan. As marcelito above says, we residents of Japan come first, not Big Parma's profits. Anyone want to argue about that?
1glenn
I trust the US pharma industry about as far as I can throw them.
anon_
They could start by banning doctors from prescribing medicine that people can buy over the counter. Then maybe limit non critical patent visits to twice a month instead of the standard every five days.
Oh and, screw the global drug companies and their overpriced drugs. More countries need to set the prices like Japan does.
mmwkdw
I wonder if they were considering asking Martin Shkreli for advice ?